MULTIROS glatiramer acetate 20 mg/1mL solution for injection prefilled syringe

País: Australia

Idioma: inglés

Fuente: Department of Health (Therapeutic Goods Administration)

Ingredientes activos:

glatiramer acetate, Quantity: 20 mg/mL

Disponible desde:

Juno Pharmaceuticals Pty Ltd

formulario farmacéutico:

Injection, solution

Composición:

Excipient Ingredients: mannitol; water for injections

Vía de administración:

Subcutaneous

Unidades en paquete:

28

tipo de receta:

(S4) Prescription Only Medicine

indicaciones terapéuticas:

Reduction of the frequency of relapses in patients with Relapsing Remitting Multiple Sclerosis.,Treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent MRI lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Resumen del producto:

Visual Identification: Clear solution in a clear, colourless glass syringe equipped with needle covered by a needle shield, stopper and piston rod.; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store at 2 to 8 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Estado de Autorización:

Registered

Fecha de autorización:

2020-11-12